A. Santoro

Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.

A. Santoro, G. Bonadonna, R. Zucali, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II

T. Gauler, A. Santoro, M. D. de Jonge, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized phase II study of danusertib (D) in second-line metastatic castration-resistant prostate cancer (CRPC).

M. Mariani, S. Tagawa, J. Bleuse, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy.

W. Scheithauer, E. Van Cutsem, B. Neyns, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer.

G. Scagliotti, E. Felip, A. Santoro, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.